Early Detection and Monitoring of Vulnerable Myocardium in Patients Receiving Chemotherapy: Is It Time to Change Tracks?  Ragavendra R. Baliga, MD, MBA 

Slides:



Advertisements
Similar presentations
Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.
Advertisements

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Identification of acutely ischemic myocardium using.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Tolerability and efficacy of carvedilol in patients.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between tumor necrosis factor-alpha.
Date of download: 11/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Targeted Left Ventricular Lead Placement to Guide.
Congestive heart failure: Treat the disease, not the symptom—Return to normalcy  Gerald D. Buckberg, MD  The Journal of Thoracic and Cardiovascular Surgery 
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive.
Sports Medicine Statistics
Never Too Late to Drink From the Fountain of Youth
Preface Heart Failure Clinics
Editorial Heart Failure Clinics
Ragavendra R. Baliga, MD, MBA  Heart Failure Clinics 
Reducing the Burden of Stage B Heart Failure and the Global Pandemic of Cardiovascular Disease: Time to Go to War with the “Barefoot” Troops!  Ragavendra.
Ragavendra R. Baliga, MD, MBA  Heart Failure Clinics 
Ragavendra R. Baliga, MD, MBA  Heart Failure Clinics 
Editorial: Depression in Heart Failure is Double Trouble: Warding off the Blues Requires Early Screening  Ragavendra R. Baliga, MD, MBA  Heart Failure.
Preface Heart Failure Clinics Volume 5, Issue 3, (July 2009)
Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.
The Journey to Adult Congenital Heart Disease
Volume 2, Issue 3, Pages xi-xiii (July 2006)
Figure 6 Speckle tracking echocardiography to
Changes in Left Ventricular Function After Mitral Valve Repair for Severe Organic Mitral Regurgitation  Tomasz G. Witkowski, MD, James D. Thomas, MD,
Nat. Rev. Cardiol. doi: /nrcardio
CardioRenal Disease Cardiology Clinics
Editorial Heart Failure Clinics
Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.
Reducing the Burden of Stage B Heart Failure and the Global Pandemic of Cardiovascular Disease: Time to Go to War with the “Barefoot” Troops!  Ragavendra.
Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads
Alan G. Japp et al. JACC 2016;67: Differentiation of Athlete’s Heart From Early DCM by Myocardial Deformation Imaging Two-dimensional speckle.
Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the “Obesity Paradox”  Carl J. Lavie, MD, Richard V.
Editorial Heart Failure Clinics
Which Arterial Conduit
Nat. Rev. Cardiol. doi: /nrcardio
Heart Failure: A Global Pandemic and Not Just a Disease of the West
Editorial Heart Failure Clinics
A Journey into the Science of Cardiovascular Chronobiology
Douglas L. Mann, MD, Michael A. Acker, MD, Mariell Jessup, MD, Hani N
β-Blockers in Heart Failure: Breaking Tradition to Avoid Diabetes?
Regional Left Ventricular Reverse Remodeling After Myectomy in Hypertrophic Cardiomyopathy  Jingjin Wang, PhD, Xin Sun, MD, Minghu Xiao, MD, Minghui Zhang,
Volume 10, Issue 4, Pages ix-x (October 2014)
Volume 7, Issue 2, Pages xix-xx (April 2011)
Clinical Trials to “Real-World” Heart Failure: Applying Risk Stratification to Deliver Personalized Care  Ragavendra R. Baliga, MD, MBA  Heart Failure.
Echocardiographic Assessment of Left Ventricular Systolic Function: An Overview of Contemporary Techniques, Including Speckle-Tracking Echocardiography 
The RIGHT Heart International NETwork (RIGHT-NET): A Road Map Through the Right Heart-Pulmonary Circulation Unit  Eduardo Bossone, MD, PhD, FCCP, FESC,
Congestive heart failure: Treat the disease, not the symptom—Return to normalcy  Gerald D. Buckberg, MD  The Journal of Thoracic and Cardiovascular Surgery 
Editorial Heart Failure Clinics
Pulmonary Hypertension
Prediction of All-Cause Mortality by the Left Atrial Volume Index in Patients With Normal Left Ventricular Filling Pressure and Preserved Ejection Fraction 
Bar chart of systolic function in healthy individuals, HCM LVH− patients and HCM LVH+ patients. GLS was significantly worse in the HCM LVH+ patients compared.
Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy  Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.
Baseline Left Ventricular Volume and Shape as Determinants of Reverse Remodeling Induced by Surgical Ventricular Reconstruction  Marisa Di Donato, MD,
Preface Heart Failure Clinics
Himanshu J. Patel, MDa, James J. Pilla, PhDa, David J
Biomarkers of Heart Failure: Past, Present, and Future
Atrial Fibrillation and Heart Failure: It Takes Two to Tango
Aortic Regurgitation With Markedly Reduced Left Ventricular Function Is Not a Contraindication for Aortic Valve Replacement  Tsuyoshi Kaneko, MD, Julius.
Editorial Heart Failure Clinics
Indexed Left Ventricular Dimensions Best Predict Survival After Aortic Valve Replacement in Patients With Aortic Valve Regurgitation  Morgan L. Brown,
On the Road from Gene to Therapy in Inherited Cardiomyopathies
Left Ventricular Volume Predicts Postoperative Course in Patients With Ischemic Cardiomyopathy  Atsushi Yamaguchi, Takashi Ino, Hideo Adachi, Seiichiro.
A World View of Heart Failure Requiring Hospitalization
Heart Failure with Preserved Ejection Fraction: A Bouillabaisse
Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction  Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),
Echocardiographic Predictors of Left Ventricular Function and Clinical Outcomes After Successful Mitral Valve Repair: Conventional Two-Dimensional Versus.
The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure  Nathan Wm. Skelley, BS, Jeremiah.
Current Status of Left Ventricular Assist Device Therapy
Statins or Status Quo? Heart Failure Clinics
Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction  John Alfred Carr, MD, Benjamin E Haithcock,
Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.
Presentation transcript:

Early Detection and Monitoring of Vulnerable Myocardium in Patients Receiving Chemotherapy: Is It Time to Change Tracks?  Ragavendra R. Baliga, MD, MBA  Heart Failure Clinics  Volume 7, Issue 3, Pages xiii-xix (July 2011) DOI: 10.1016/j.hfc.2011.05.001 Copyright © 2011 Terms and Conditions

Fig. 1 Adjusted Kaplan-Meier estimates of survival according to the underlying cause of cardiomyopathy. Only idiopathic cardiomyopathy and cardiomyopathy caused by causes for which survival was significantly different from that in patients with idiopathic cardiomyopathy are shown. (From Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342(15):1077–84; with permission.) Heart Failure Clinics 2011 7, xiii-xixDOI: (10.1016/j.hfc.2011.05.001) Copyright © 2011 Terms and Conditions

Fig. 2 Carvedilol in anthracycline-induced cardiomyopathy. Left ventricular ejection fraction (EF) at baseline (black bars) and after chemotherapy (white bars) in carvedilol (N = 25) and control (N = 25) groups. Data expressed as mean values. (From Kalay N, Basar E, Ozdogru I, et al. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 2006;48(11):2258–62; with permission.) Heart Failure Clinics 2011 7, xiii-xixDOI: (10.1016/j.hfc.2011.05.001) Copyright © 2011 Terms and Conditions

Fig. 3 Peak longitudinal strain obtained using speckle tracking during systolic contraction from 6 regions of interest that are angle independent and occur almost simultaneously in this normal patient. AVC, aortic valve closure; GS, global strain index. (From St John Sutton MG, Plappert T, Rahmouni H. Assessment of left ventricular systolic function by echocardiography. Heart Fail Clin 2009;5(2):177–90.) Heart Failure Clinics 2011 7, xiii-xixDOI: (10.1016/j.hfc.2011.05.001) Copyright © 2011 Terms and Conditions

Fig. 4 A plot out of circumferential (C), radial (R), and longitudinal (L) strains from a normal patient in whom there is the usual regional temporal coordination of contraction. (From St John Sutton MG, Plappert T, Rahmouni H. Assessment of left ventricular systolic function by echocardiography. Heart Fail Clin 2009;5(2):177–90.) Heart Failure Clinics 2011 7, xiii-xixDOI: (10.1016/j.hfc.2011.05.001) Copyright © 2011 Terms and Conditions

Ragavendra R. Baliga, MD, MBA, Consulting Editor Heart Failure Clinics 2011 7, xiii-xixDOI: (10.1016/j.hfc.2011.05.001) Copyright © 2011 Terms and Conditions

James B. Young, MD, Consulting Editor Heart Failure Clinics 2011 7, xiii-xixDOI: (10.1016/j.hfc.2011.05.001) Copyright © 2011 Terms and Conditions